Global Sustained Release Injectables Sales Market Report 2023

Report ID: 845689 | Published Date: Jan 2025 | No. of Page: 148 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Sustained Release Injectables Market Overview
    1.1 Sustained Release Injectables Product Scope
    1.2 Sustained Release Injectables Segment by Type
        1.2.1 Global Sustained Release Injectables Sales by Type (2016 & 2021 & 2027)
        1.2.2 Naltrexone
        1.2.3 Exenatide
        1.2.4 Estradiol
        1.2.5 Other
    1.3 Sustained Release Injectables Segment by Application
        1.3.1 Global Sustained Release Injectables Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Diabetes
        1.3.3 Leukemia
        1.3.4 Acromegaly
        1.3.5 Other
    1.4 Sustained Release Injectables Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Sustained Release Injectables Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Sustained Release Injectables Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Sustained Release Injectables Price Trends (2016-2027)

2 Sustained Release Injectables Estimates and Forecasts by Region
    2.1 Global Sustained Release Injectables Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Sustained Release Injectables Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
        2.2.2 Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
    2.3 Global Sustained Release Injectables Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Sustained Release Injectables Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Sustained Release Injectables Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.2 Europe Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.3 China Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.4 Japan Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.6 India Sustained Release Injectables Estimates and Projections (2016-2027)
3 Global Sustained Release Injectables Competition Landscape by Players
    3.1 Global Top Sustained Release Injectables Players by Sales (2016-2021)
    3.2 Global Top Sustained Release Injectables Players by Revenue (2016-2021)
    3.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2020)
    3.4 Global Sustained Release Injectables Average Price by Company (2016-2021)
    3.5 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Sustained Release Injectables Market Size by Type
    4.1 Global Sustained Release Injectables Historic Market Review by Type (2016-2021)
        4.1.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
        4.1.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
        4.1.3 Global Sustained Release Injectables Price by Type (2016-2021)
    4.2 Global Sustained Release Injectables Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
        4.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2022-2027)
        4.2.3 Global Sustained Release Injectables Price Forecast by Type (2022-2027)
5 Global Sustained Release Injectables Market Size by Application
    5.1 Global Sustained Release Injectables Historic Market Review by Application (2016-2021)
        5.1.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
        5.1.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
        5.1.3 Global Sustained Release Injectables Price by Application (2016-2021)
    5.2 Global Sustained Release Injectables Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
        5.2.2 Global Sustained Release Injectables Revenue Forecast by Application (2022-2027)
        5.2.3 Global Sustained Release Injectables Price Forecast by Application (2022-2027)

6 North America Sustained Release Injectables Market Facts & Figures
    6.1 North America Sustained Release Injectables Sales by Company
        6.1.1 North America Sustained Release Injectables Sales by Company (2016-2021)
        6.1.2 North America Sustained Release Injectables Revenue by Company (2016-2021)
    6.2 North America Sustained Release Injectables Sales Breakdown by Type
        6.2.1 North America Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        6.2.2 North America Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    6.3 North America Sustained Release Injectables Sales Breakdown by Application
        6.3.1 North America Sustained Release Injectables Sales Breakdown by Application (2016-2021)
        6.3.2 North America Sustained Release Injectables Sales Breakdown by Application (2022-2027)

7 Europe Sustained Release Injectables Market Facts & Figures
    7.1 Europe Sustained Release Injectables Sales by Company
        7.1.1 Europe Sustained Release Injectables Sales by Company (2016-2021)
        7.1.2 Europe Sustained Release Injectables Revenue by Company (2016-2021)
    7.2 Europe Sustained Release Injectables Sales Breakdown by Type
        7.2.1 Europe Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    7.3 Europe Sustained Release Injectables Sales Breakdown by Application
        7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Sustained Release Injectables Market Facts & Figures
    8.1 China Sustained Release Injectables Sales by Company
        8.1.1 China Sustained Release Injectables Sales by Company (2016-2021)
        8.1.2 China Sustained Release Injectables Revenue by Company (2016-2021)
    8.2 China Sustained Release Injectables Sales Breakdown by Type
        8.2.1 China Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        8.2.2 China Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    8.3 China Sustained Release Injectables Sales Breakdown by Application
        8.3.1 China 314 Sales Breakdown by Application (2016-2021)
        8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Sustained Release Injectables Market Facts & Figures
    9.1 Japan Sustained Release Injectables Sales by Company
        9.1.1 Japan Sustained Release Injectables Sales by Company (2016-2021)
        9.1.2 Japan Sustained Release Injectables Revenue by Company (2016-2021)
    9.2 Japan Sustained Release Injectables Sales Breakdown by Type
        9.2.1 Japan Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    9.3 Japan Sustained Release Injectables Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sustained Release Injectables Market Facts & Figures
    10.1 Southeast Asia Sustained Release Injectables Sales by Company
        10.1.1 Southeast Asia Sustained Release Injectables Sales by Company (2016-2021)
        10.1.2 Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021)
    10.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type
        10.2.1 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Sustained Release Injectables Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Sustained Release Injectables Market Facts & Figures
    11.1 India Sustained Release Injectables Sales by Company
        11.1.1 India Sustained Release Injectables Sales by Company (2016-2021)
        11.1.2 India Sustained Release Injectables Revenue by Company (2016-2021)
    11.2 India Sustained Release Injectables Sales Breakdown by Type
        11.2.1 India Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        11.2.2 India Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    11.3 India Sustained Release Injectables Sales Breakdown by Application
        11.3.1 India Sustained Release Injectables Sales Breakdown by Application (2016-2021)
        11.3.2 India Sustained Release Injectables Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sustained Release Injectables Business
    12.1 AstraZeneca
        12.1.1 AstraZeneca Corporation Information
        12.1.2 AstraZeneca Business Overview
        12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 AstraZeneca Sustained Release Injectables Products Offered
        12.1.5 AstraZeneca Recent Development
    12.2 Eli Lilly
        12.2.1 Eli Lilly Corporation Information
        12.2.2 Eli Lilly Business Overview
        12.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Eli Lilly Sustained Release Injectables Products Offered
        12.2.5 Eli Lilly Recent Development
    12.3 Sanofi
        12.3.1 Sanofi Corporation Information
        12.3.2 Sanofi Business Overview
        12.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Sanofi Sustained Release Injectables Products Offered
        12.3.5 Sanofi Recent Development
    12.4 Roche
        12.4.1 Roche Corporation Information
        12.4.2 Roche Business Overview
        12.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Roche Sustained Release Injectables Products Offered
        12.4.5 Roche Recent Development
    12.5 Novartis
        12.5.1 Novartis Corporation Information
        12.5.2 Novartis Business Overview
        12.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Novartis Sustained Release Injectables Products Offered
        12.5.5 Novartis Recent Development
    12.6 Aurobindo
        12.6.1 Aurobindo Corporation Information
        12.6.2 Aurobindo Business Overview
        12.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Aurobindo Sustained Release Injectables Products Offered
        12.6.5 Aurobindo Recent Development
    12.7 Avadel
        12.7.1 Avadel Corporation Information
        12.7.2 Avadel Business Overview
        12.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Avadel Sustained Release Injectables Products Offered
        12.7.5 Avadel Recent Development
    12.8 Biomarin
        12.8.1 Biomarin Corporation Information
        12.8.2 Biomarin Business Overview
        12.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Biomarin Sustained Release Injectables Products Offered
        12.8.5 Biomarin Recent Development
    12.9 Camurus
        12.9.1 Camurus Corporation Information
        12.9.2 Camurus Business Overview
        12.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Camurus Sustained Release Injectables Products Offered
        12.9.5 Camurus Recent Development
    12.10 Critical Pharmaceuticals
        12.10.1 Critical Pharmaceuticals Corporation Information
        12.10.2 Critical Pharmaceuticals Business Overview
        12.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered
        12.10.5 Critical Pharmaceuticals Recent Development
    12.11 Alkermes
        12.11.1 Alkermes Corporation Information
        12.11.2 Alkermes Business Overview
        12.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Alkermes Sustained Release Injectables Products Offered
        12.11.5 Alkermes Recent Development
    12.12 Amylin
        12.12.1 Amylin Corporation Information
        12.12.2 Amylin Business Overview
        12.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Amylin Sustained Release Injectables Products Offered
        12.12.5 Amylin Recent Development
    12.13 Ascendis Pharma
        12.13.1 Ascendis Pharma Corporation Information
        12.13.2 Ascendis Pharma Business Overview
        12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Ascendis Pharma Sustained Release Injectables Products Offered
        12.13.5 Ascendis Pharma Recent Development
    12.14 Taiwan Liposome Company
        12.14.1 Taiwan Liposome Company Corporation Information
        12.14.2 Taiwan Liposome Company Business Overview
        12.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Taiwan Liposome Company Sustained Release Injectables Products Offered
        12.14.5 Taiwan Liposome Company Recent Development

13 Sustained Release Injectables Manufacturing Cost Analysis
    13.1 Sustained Release Injectables Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Sustained Release Injectables
    13.4 Sustained Release Injectables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Sustained Release Injectables Distributors List
    14.3 Sustained Release Injectables Customers

15 Market Dynamics
    15.1 Sustained Release Injectables Market Trends
    15.2 Sustained Release Injectables Drivers
    15.3 Sustained Release Injectables Market Challenges
    15.4 Sustained Release Injectables Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Sustained Release Injectables Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Sustained Release Injectables Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Sustained Release Injectables Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Sustained Release Injectables Sales (K Units) by Region (2016-2021)
    Table 5. Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
    Table 6. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Sustained Release Injectables Revenue Share by Region (2016-2021)
    Table 8. Global Sustained Release Injectables Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Sustained Release Injectables Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Sustained Release Injectables Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Sustained Release Injectables Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Sustained Release Injectables Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Sustained Release Injectables Sales Share by Company (2016-2021)
    Table 14. Global Sustained Release Injectables Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Sustained Release Injectables Revenue Share by Company (2016-2021)
    Table 16. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2020)
    Table 17. Global Sustained Release Injectables Average Price (USD/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Sustained Release Injectables Manufacturing Sites and Area Served
    Table 19. Manufacturers Sustained Release Injectables Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Sustained Release Injectables Sales (K Units) by Type (2016-2021)
    Table 22. Global Sustained Release Injectables Sales Share by Type (2016-2021)
    Table 23. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Sustained Release Injectables Price (USD/Unit) by Type (2016-2021)
    Table 25. Global Sustained Release Injectables Sales Share by Type (2022-2027)
    Table 26. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Sustained Release Injectables Revenue Share by Type (2022-2027)
    Table 28. Global Sustained Release Injectables Price (USD/Unit) by Type (2022-2027)
    Table 29. Global Sustained Release Injectables Sales (K Units) by Application (2016-2021) 
    Table 30. Global Sustained Release Injectables Sales Share by Application (2016-2021)
    Table 31. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Sustained Release Injectables Price (USD/Unit) by Application (2016-2021)
    Table 33. Global Sustained Release Injectables Sales (K Units) by Application (2022-2027)
    Table 34. Global Sustained Release Injectables Sales Share by Application (2022-2027)
    Table 35. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Sustained Release Injectables Revenue Share by Application (2022-2027)
    Table 37. Global Sustained Release Injectables Price (USD/Unit) by Application (2022-2027)
    Table 38. North America Sustained Release Injectables Sales (K Units) by Company (2016-2021)
    Table 39. North America Sustained Release Injectables Sales Market Share by Company (2016-2021)
    Table 40. North America Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Sustained Release Injectables Revenue Market Share by Company (2016-2021)
    Table 42. North America Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
    Table 43. North America Sustained Release Injectables Sales Market Share by Type (2016-2021)
    Table 44. North America Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
    Table 45. North America Sustained Release Injectables Sales Market Share by Type (2022-2027)
    Table 46. North America Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
    Table 47. North America Sustained Release Injectables Sales Market Share by Application (2016-2021)
    Table 48. North America Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
    Table 49. North America Sustained Release Injectables Sales Market Share by Application (2022-2027)
    Table 50. Europe Sustained Release Injectables Sales (K Units) by Company (2016-2021)
    Table 51. Europe Sustained Release Injectables Sales Market Share by Company (2016-2021)
    Table 52. Europe Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Sustained Release Injectables Revenue Market Share by Company (2016-2021)
    Table 54. Europe Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Sustained Release Injectables Sales Market Share by Type (2016-2021)
    Table 56. Europe Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Sustained Release Injectables Sales Market Share by Type (2022-2027)
    Table 58. Europe Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Sustained Release Injectables Sales Market Share by Application (2016-2021)
    Table 60. Europe Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Sustained Release Injectables Sales Market Share by Application (2022-2027)
    Table 62. China Sustained Release Injectables Sales (K Units) by Company (2016-2021)
    Table 63. China Sustained Release Injectables Sales Market Share by Company (2016-2021)
    Table 64. China Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Sustained Release Injectables Revenue Market Share by Company (2016-2021)
    Table 66. China Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
    Table 67. China Sustained Release Injectables Sales Market Share by Type (2016-2021)
    Table 68. China Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
    Table 69. China Sustained Release Injectables Sales Market Share by Type (2022-2027)
    Table 70. China Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
    Table 71. China Sustained Release Injectables Sales Market Share by Application (2016-2021)
    Table 72. China Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
    Table 73. China Sustained Release Injectables Sales Market Share by Application (2022-2027)
    Table 74. Japan Sustained Release Injectables Sales (K Units) by Company (2016-2021)
    Table 75. Japan Sustained Release Injectables Sales Market Share by Company (2016-2021)
    Table 76. Japan Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Sustained Release Injectables Revenue Market Share by Company (2016-2021)
    Table 78. Japan Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Sustained Release Injectables Sales Market Share by Type (2016-2021)
    Table 80. Japan Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Sustained Release Injectables Sales Market Share by Type (2022-2027)
    Table 82. Japan Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Sustained Release Injectables Sales Market Share by Application (2016-2021)
    Table 84. Japan Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Sustained Release Injectables Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Sustained Release Injectables Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Sustained Release Injectables Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Sustained Release Injectables Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2022-2027)
    Table 98. India Sustained Release Injectables Sales (K Units) by Company (2016-2021)
    Table 99. India Sustained Release Injectables Sales Market Share by Company (2016-2021)
    Table 100. India Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Sustained Release Injectables Revenue Market Share by Company (2016-2021)
    Table 102. India Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
    Table 103. India Sustained Release Injectables Sales Market Share by Type (2016-2021)
    Table 104. India Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
    Table 105. India Sustained Release Injectables Sales Market Share by Type (2022-2027)
    Table 106. India Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
    Table 107. India Sustained Release Injectables Sales Market Share by Application (2016-2021)
    Table 108. India Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
    Table 109. India Sustained Release Injectables Sales Market Share by Application (2022-2027)
    Table 110. AstraZeneca Corporation Information
    Table 111. AstraZeneca Description and Business Overview
    Table 112. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. AstraZeneca Sustained Release Injectables Product
    Table 114. AstraZeneca Recent Development
    Table 115. Eli Lilly Corporation Information
    Table 116. Eli Lilly Description and Business Overview
    Table 117. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Eli Lilly Sustained Release Injectables Product
    Table 119. Eli Lilly Recent Development
    Table 120. Sanofi Corporation Information
    Table 121. Sanofi Description and Business Overview
    Table 122. Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. Sanofi Sustained Release Injectables Product
    Table 124. Sanofi Recent Development
    Table 125. Roche Corporation Information
    Table 126. Roche Description and Business Overview
    Table 127. Roche Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. Roche Sustained Release Injectables Product
    Table 129. Roche Recent Development
    Table 130. Novartis Corporation Information
    Table 131. Novartis Description and Business Overview
    Table 132. Novartis Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. Novartis Sustained Release Injectables Product
    Table 134. Novartis Recent Development
    Table 135. Aurobindo Corporation Information
    Table 136. Aurobindo Description and Business Overview
    Table 137. Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. Aurobindo Sustained Release Injectables Product
    Table 139. Aurobindo Recent Development
    Table 140. Avadel Corporation Information
    Table 141. Avadel Description and Business Overview
    Table 142. Avadel Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Avadel Sustained Release Injectables Product
    Table 144. Avadel Recent Development
    Table 145. Biomarin Corporation Information
    Table 146. Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 147. Biomarin Description and Business Overview
    Table 148. Biomarin Sustained Release Injectables Product
    Table 149. Biomarin Recent Development
    Table 150. Camurus Corporation Information
    Table 151. Camurus Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 152. Camurus Description and Business Overview
    Table 153. Camurus Sustained Release Injectables Product
    Table 154. Camurus Recent Development
    Table 155. Critical Pharmaceuticals Corporation Information
    Table 156. Critical Pharmaceuticals Description and Business Overview
    Table 157. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. Critical Pharmaceuticals Sustained Release Injectables Product
    Table 159. Critical Pharmaceuticals Recent Development
    Table 160. Alkermes Corporation Information
    Table 161. Alkermes Description and Business Overview
    Table 162. Alkermes Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 163. Alkermes Sustained Release Injectables Product
    Table 164. Alkermes Recent Development
    Table 165. Amylin Corporation Information
    Table 166. Amylin Description and Business Overview
    Table 167. Amylin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 168. Amylin Sustained Release Injectables Product
    Table 169. Amylin Recent Development
    Table 170. Ascendis Pharma Corporation Information
    Table 171. Ascendis Pharma Description and Business Overview
    Table 172. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 173. Ascendis Pharma Sustained Release Injectables Product
    Table 174. Ascendis Pharma Recent Development
    Table 175. Taiwan Liposome Company Corporation Information
    Table 176. Taiwan Liposome Company Description and Business Overview
    Table 177. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 178. Taiwan Liposome Company Sustained Release Injectables Product
    Table 179. Taiwan Liposome Company Recent Development
    Table 180. Production Base and Market Concentration Rate of Raw Material
    Table 181. Key Suppliers of Raw Materials
    Table 182. Sustained Release Injectables Distributors List
    Table 183. Sustained Release Injectables Customers List
    Table 184. Sustained Release Injectables Market Trends
    Table 185. Sustained Release Injectables Market Drivers
    Table 186. Sustained Release Injectables Market Challenges
    Table 187. Sustained Release Injectables Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sustained Release Injectables Product Picture
    Figure 2. Global Sustained Release Injectables Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Sustained Release Injectables Sales Market Share by Application in 2021 & 2027
    Figure 6. Diabetes Examples
    Figure 7. Leukemia Examples
    Figure 8. Acromegaly Examples
    Figure 9. Other Examples
    Figure 10. Global Sustained Release Injectables Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Sustained Release Injectables Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Sustained Release Injectables Sales (K Units) Growth Rate (2016-2027)
    Figure 13. Global Sustained Release Injectables Price Trends Growth Rate (2016-2027) (USD/Unit)
    Figure 14. Global Sustained Release Injectables Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Sustained Release Injectables Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Sustained Release Injectables Sales (K Units) Growth Rate (2016-2027)
    Figure 18. Europe Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Sustained Release Injectables Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Sustained Release Injectables Players Market Share by Revenue in Sustained Release Injectables: 2016 & 2020
    Figure 29. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Sustained Release Injectables Revenue Share by Type (2016-2021)
    Figure 31. Global Sustained Release Injectables Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Sustained Release Injectables Revenue Share by Application (2016-2021)
    Figure 33. Global Sustained Release Injectables Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Sustained Release Injectables Sales Market Share by Type in 2020
    Figure 35. North America Sustained Release Injectables Sales Market Share by Application in 2020
    Figure 36. Europe Sustained Release Injectables Sales Market Share by Type in 2020
    Figure 37. Europe Sustained Release Injectables Sales Market Share by Application in 2020
    Figure 38. China Sustained Release Injectables Sales Market Share by Type in 2020
    Figure 39. China Sustained Release Injectables Sales Market Share by Application in 2020
    Figure 40. Japan Sustained Release Injectables Sales Market Share by Type in 2020
    Figure 41. Japan Sustained Release Injectables Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Sustained Release Injectables Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Sustained Release Injectables Sales Market Share by Application in 2020
    Figure 44. India Sustained Release Injectables Sales Market Share by Type in 2020
    Figure 45. India Sustained Release Injectables Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Sustained Release Injectables 
    Figure 48. Manufacturing Process Analysis of Sustained Release Injectables
    Figure 49. Sustained Release Injectables Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation 
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Eli Lilly
Sanofi
Roche
Novartis
Aurobindo
Avadel
Biomarin
Camurus
Critical Pharmaceuticals
Alkermes
Amylin
Ascendis Pharma
Taiwan Liposome Company
Frequently Asked Questions
Sustained Release Injectables report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sustained Release Injectables report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sustained Release Injectables report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cosmetic Colorants

The raw material that makes cosmetic give colour and lustre and improve cosmetic colour and lustr ... Read More

Medical Mixture

Directly used in the medical industry, the gas mixture is mainly used as a coolant and disinfecta ... Read More